Table 2 NAFLD/NASH histological scores of the study population (n(%))
From: Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD)
Variable | All patients (53) |
|---|---|
Steatosis | |
0 | 0 (0) |
1 | 21 (39.6) |
2 | 24 (45.3) |
3 | 8 (15.1) |
Ballooning | |
0 | 9 (17.0) |
1 | 38 (71.7) |
2 | 6 (11.3) |
Inflammation | |
0 | 4 (7.5) |
1 | 40 (75.5) |
2 | 9 (17.0) |
3 | 0 (0) |
NAS > 4 | 13 (24.5) |
Fibrosis | |
0 | 2 (3.8) |
1 | 38 (71.7) |
2 | 13 (24.5) |
3 | 0 (0) |
4 | 0 (0) |